#ASCO23 (Photo: Senior editor Max Gelman for Endpoints News)

J&J takes vic­to­ry lap on its Carvyk­ti da­ta. But how many pa­tients will take it — and when? #AS­CO23

CHICA­GO — When Ley­la Shune first heard about a leaked ab­stract last month de­scrib­ing a dra­mat­ic 74% re­duc­tion in the risk of dis­ease pro­gres­sion or …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.